Add Row
Add Element
cropper
update

Provider Impact

update
Add Element
  • Home
  • Categories
    • Medicare + RTM
    • Pharmacy Insights
    • Provider Spotlights
    • HR & Staff Benefits
  • Featured Business Profiles
June 24.2025
3 Minutes Read

Why North Dakota Health System's Move to Epic EHR Matters for Healthcare Providers

Becker's Hospital Review logo on a blue background.

Trinity Health's Leap into the Future with Epic EHR

In an exciting development for healthcare in Minot, North Dakota, Trinity Health has embarked on an 18-month project to replace its current electronic health record (EHR) system with Epic. Scheduled to go live on November 1, 2026, this transition is set to enhance patient care and operational efficiency significantly. John M. Kutch, Trinity Health's president and CEO, expressed that this investment not only modernizes the technology within the health system but also reinforces their commitment to the health and well-being of the community they serve.

Why Transitioning to Epic EHR is a Game-Changer

Switching to a more robust EHR system like Epic can have wide-reaching implications for healthcare providers and patients alike. Epic systems are known for their comprehensive capabilities that promote interoperability—a crucial factor in today's integrated healthcare environment. With improved data accessibility, healthcare professionals can spend less time on administrative tasks and more on patient care.

The Impact on Healthcare Workflow and Patient Engagement

This strategic move is about more than just technology—it’s about how healthcare providers can better serve their patients. Epic’s advanced functionalities allow healthcare workers to engage patients more effectively and streamline workflows through features like patient engagement tools. Additionally, the integration of remote therapeutic monitoring (RTM) programs within the Epic ecosystem can transform patient care, especially for those managing chronic conditions.

Boosting Efficiency with Healthcare Automation

Healthcare automation is another critical area where Epic shines. With the integration of voice AI agents and missed call automation, staff productivity can be maximized, freeing up valuable time for healthcare workers. When administrative burdens are minimized, it leads to enhanced healthcare staff retention, as teams can focus on delivering quality care instead of getting bogged down in paperwork.

The Financial Aspect: How This Affects Practice Revenue

Trinity Health's investment in Epic also presents opportunities for financial optimization. Automated billing systems can help recover lost revenue from insurance underpayments and streamline Medicare reimbursement processes. From practices to independent pharmacies, adopting EHRs like Epic can yield significant clinic cost savings and enhance pharmacy profitability.

Enhancing Employee Health Benefits Through Technology

Moreover, as healthcare becomes increasingly complex, providing employees with the right tools can enhance their benefits and overall job satisfaction. With pre-tax benefit plans now encompassing telehealth revenue and digital front desks, providers can utilize Epic to modernize employee health benefits effectively. As a result, a healthier workforce contributes to better patient outcomes.

What Lies Ahead: Future Predictions for EHR Systems

The transition to Epic is just the beginning. As the healthcare industry continues to advance, the focus will undoubtedly shift towards more niche solutions like pharmacy-focused innovations and telehealth integrations that improve comprehensive patient care. Organizations that proactively embrace these changes will likely thrive while those that resist may fall behind.

Conclusion: Taking Proactive Steps in Healthcare

The strategic decision by Trinity Health to switch to Epic demonstrates a forward-thinking approach in a rapidly evolving healthcare landscape. With a commitment to better technology and enhanced patient care, it sets a precedent for other healthcare systems to follow. For healthcare professionals looking to enhance their practice and remain competitive, now is the time to explore how digitization and automation can lead to better outcomes for both patients and providers.

As we witness Trinity Health's journey over the next 18 months, let us reflect on how such transitions impact not just one facility, but the community as a whole. It’s a reminder that in healthcare, progress is always possible, and the next great innovation could be just around the corner.

Provider Spotlights

6 Views

0 Comments

Write A Comment

*
*
Related Posts All Posts
11.07.2025

How Fish Oil Can Significantly Reduce Cardiovascular Events in Dialysis Patients

Update Groundbreaking Research: Fish Oil's Role in Cardiovascular Health The newly unveiled results from the PISCES trial are sending ripples through the world of nephrology and cardiovascular research. A comprehensive analysis revealed that daily supplementation with fish oil significantly lowers the risk of serious cardiovascular events in patients undergoing maintenance hemodialysis. Over a period of 3.5 years, participants who consumed 4 grams of fish oil daily experienced a staggering 43% reduction in serious cardiovascular events compared to a placebo group, according to findings presented by Dr. Charmaine Lok at the American Society of Nephrology's Kidney Week meeting. Understanding the Impact of Fish Oil These findings highlight the potential benefits of incorporating eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), the main components of fish oil, into treatment regimens for hemodialysis patients. With conditions such as acute cardiac death, myocardial infarction, and stroke, all showing decreased occurrence in the fish oil group, the implications for clinical practice are profound. As noted by Dr. Lok, "We know that if someone had an event, you're more likely to have a future event." However, regular fish oil users had comparable risks to individuals without previous cardiovascular events, indicating the supplement's potential to reset or mitigate cardiovascular risks even after prior incidents. The Need for Caution: Not All That Glitters Is Gold Despite these promising findings, experts are urging caution before hastily integrating fish oil into standard treatment protocols for hemodialysis patients. Collaborative editorialists, Dr. Finnian McCausland and Dr. David Charytan, point out that the medical community has seen numerous instances where initial trial-sparked enthusiasm subsequently diminished upon further investigation. As they advise, "We should pause before accepting such remarkable results as gospel.” The necessity for additional confirmatory trials cannot be overstated, especially as dialytic populations have often been neglected in past cardiovascular studies. Exploring the Underlying Mechanisms What makes fish oil such an appealing option for combating cardiovascular risk? According to Dr. Lok, the n-3 polyunsaturated fatty acids exhibit various beneficial properties, including anti-thrombotic, anti-inflammatory, and anti-arrhythmic effects. These characteristics align them well with the cardiovascular complications frequently seen in hemodialysis patients, who face death rates from cardiovascular issues that dwarf those of the general population by a factor of 20. Current Guidelines: A Call for Change While the National Kidney Foundation currently advocates for kidney patients to consume fresh fish twice weekly, it lacks a definitive stance on fish oil supplementation. The النتائج of this groundbreaking trial may prompt healthcare providers to reconsider existing guidelines and potentially endorse fish oil as a valuable supplement in their practice. Healthcare Implications: Shaping Future Protocols Given the urgent need for effective cardiovascular interventions in the hemodialysis population, these findings should challenge clinicians to explore new avenues to enhance patient care. The marked differences in cardiovascular risk, particularly for those with prior events, suggest the possibility of a turning point in treatment recommendations. As such, discussions around healthcare policy should evolve to incorporate evidence-based practices that prioritize patient safety and health outcomes. Conclusion: A Glimmer of Hope for Patients The hope remains that further studies will validate these findings, providing a clearer path toward enhanced patient care in the realm of cardiovascular health for dialysis patients. As providers, nurses, and healthcare policymakers gather to discuss these results, fostering a culture of continuous education and evidence-based practice will be essential in empowering practitioners to offer the best care possible. If you found these insights valuable, consider staying informed about the latest trends in healthcare—sign up for our newsletter to receive updates on clinical research and physician spotlights that can enhance your practice and patient care strategies.

11.06.2025

Is Reducing GLP-1 Dose Frequency the Key to Sustaining Health Gains?

Update Understanding GLP-1 and Its Impact on Weight ManagementGLP-1 receptor agonists have revolutionized the treatment landscape for obesity and diabetes, providing patients with powerful tools to help manage their weight and improve metabolic health. According to Dr. Mitch Biermann from the Scripps Clinic, many patients who have met their weight goals while on GLP-1 therapies can maintain their benefits even when reducing the frequency of their doses. This finding is especially crucial for patients seeking to balance cost and efficacy in their long-term medication plans.Case Series Insights: When Less Is MoreIn a recent case series presented at the ObesityWeek annual meeting, Dr. Biermann reported intriguing results from 30 patients who decreased their dosing frequency to as little as every five to six weeks. Remarkably, 26 of these patients maintained their achieved weight, with some even experiencing additional weight loss. The study suggests that transitioning to a lower dose frequency may not only be effective but also beneficial in maintaining metabolic improvement without increasing the risk of adverse outcomes. This observation addresses a vital concern for many healthcare providers and their patients: the challenge of weight regain when abruptly stopping medication.Patient Perspectives: The Desire for De-escalationIt’s fascinating to note how patient motivations significantly influence their treatment trajectories. Dr. Biermann shares that patients often initiate discussions about de-escalating their medication before even starting. Their primary concern is typically longevity on the medications rather than the potential risks involved. Such insights highlight the importance of patient education and shared decision-making in chronic condition management.Risks of Abrupt Discontinuation: A Cautionary TalePrevious trials have established that abrupt discontinuation of GLP-1 therapy can lead to weight regain, which makes the ability to safely reduce dosage frequency such a significant finding. By positioning clinicians to support patients who are ready to transition to less frequent dosing, we may help alleviate some of the burdens associated with these therapies while still promoting patient health.Conclusive Criteria for Dose ReductionDr. Biermann emphasizes three criteria when considering dosage de-escalation: patient desire to reduce frequency, stabilization of weight or achievement of plateau, and resolution of obesity-associated comorbidities. He admits that often, patients may qualify for a change even if only two of these criteria are met. This tailored approach may open doors for more patients to optimize their treatment pathways, offering them a greater sense of empowerment.Health Metrics: Stability After Dose ReductionThe study measured critical health metrics—like body fat percentage, blood pressure, and lipid levels—at key points before and after the frequency reduction. Encouragingly, no significant changes were recorded after the transition for most patients, suggesting that a less frequent dosing schedule does not compromise health outcomes. These results provide a clear illustration of how tailored approaches in medication management can yield substantial benefits without sacrificing health.The Broader Implications: Cost-Effectiveness and Patient HealthHealthcare professionals must consider the economic implications of medication adjustments as well. As policies shift towards value-based care, strategies that enable patients to maintain health gains while optimizing medication costs become increasingly relevant. By helping patients navigate their medication regimens effectively, healthcare providers can potentially alleviate pressures on healthcare costs while ensuring better patient outcomes.Future Considerations in Obesity ManagementThis evolving conversation surrounding GLP-1 therapy emphasizes the dynamic nature of obesity management. As clinical guidelines continue to adapt, the ability to personalize treatment regimens is paramount. Ongoing research is essential to explore the long-term impacts of reduced dosing, ensuring that patient health remains at the forefront of therapeutic strategies.Call to Action: Engaging with New InsightsAs healthcare providers, keeping abreast of the latest clinical research updates and medical practices is crucial. Embracing innovative strategies in weight management medication can significantly impact patient care and outcomes. Stay informed and engage in conversations about optimizing treatment plans that are beneficial for both patients and their healthcare teams.

11.05.2025

How Recent FDA Leadership Changes Impact Vaccine Confidence and Safety

Update The Turbulent Tenure of Vinay Prasad at the FDA The recent upheaval at the FDA's Center for Biologics Evaluation and Research (CBER) under Dr. Vinay Prasad has left many in the medical community wondering about the future of vaccine regulation in the U.S. Since assuming leadership, Prasad has reportedly pushed out at least seven senior leaders, fostering an environment described by employees as dysfunctional and marked by fear. His management style, which is characterized by a lack of transparency and disregard for established protocols, has raised concerns about the center's ability to effectively oversee vaccine safety, especially at a time when public confidence in immunizations is crucial. In a recent investigative report by STAT, insiders conveyed a sense of paranoia spreading through CBER, as many employees contemplate leaving the center due to the “toxic atmosphere.” With a history of stepping over traditional channels and communicating directly with lower-ranking officials, Prasad's leadership has garnered considerable scrutiny. Notably, his abrupt firing and subsequent return to the FDA only two weeks later, reportedly backed by HHS Secretary Robert F. Kennedy Jr., has led to a culture of uncertainty within the agency. "It's worse than part one," an FDA official succinctly stated, highlighting the increasing unrest among a beleaguered workforce. The Rise of Paid Vaccine Exemptions: A Growing Concern Another alarming trend gaining traction in the vaccine landscape involves the commercialization of medical exemptions through groups like Frontline Health Advocates. For a fee of $495, parents can secure medical exemptions from vaccine requirements, which raises ethical and medical concerns, particularly amidst ongoing debates about vaccine safety and efficacy. William Lionberger, the chiropractor behind this initiative, has been able to tap into a network of anti-vaccination advocacy, effectively capitalizing on parents’ fear and confusion surrounding vaccine mandates. Critics, such as UC Law expert Dorit Reiss, emphasize that such services not only undermine public health efforts but also risk compromising children's safety. With several of the exemptions reportedly signed by questionable medical professionals, the potential for harm grows within communities that are increasingly skeptical of vaccines. The Implications of Leadership Changes in Public Health As if the situation surrounding Prasad and paid exemptions weren't disconcerting enough, the appointment of an anti-vaccine advocate to lead the Office of the Assistant Secretary for Preparedness and Response (ASPR) raises further alarms. This position is critical in managing the U.S. government's response to public health emergencies and overseeing the federal stockpile of medical supplies. The ramifications of having leadership that opposes conventional vaccine practices could hinder future public health strategies, especially as the country remains on alert for potential vaccine-preventable outbreaks. The intersection of leadership at the FDA and ASPR creates a scenario that could damage the collective health awareness necessary for effectively managing pandemics. Stakeholders in healthcare policy and public health must not underestimate the impact of these appointments on vaccine acceptance and the overall integrity of the public health response. Facing the Future: The Role of the Medical Community The ongoing narrative reinforces the need for collective vigilance within the medical community. Physicians, nurse practitioners, healthcare executives, and medical educators must engage with ongoing healthcare debates, advocating for evidence-based practices amidst growing misinformation surrounding vaccines. They can influence policy by promoting discussions about the importance of transparent regulatory practices and the necessity of scientific rigor in vaccine approvals. For healthcare providers, understanding the complexities behind these developments is essential in fostering patient trust and championing vaccine initiatives. Whether through educational outreach, participation in local healthcare policy discussions, or supporting community vaccination efforts, their role as advocates becomes more critical than ever. The challenges posed by these leadership changes and trends in vaccine skepticism necessitate strong, informed advocacy within the medical community. By fostering a dialogue that champions science and combats misinformation, medical professionals can help safeguard public health and pave the way for a more informed populace that values vaccines as essential tools for disease prevention.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*